The deacylase SIRT5 supports melanoma viability by influencing chromatin dynamics

William Giblin1,2, Lauren Bringman-Rodenbarger1, Angela H Guo1

  • 1Department of Pathology and.

Insights

Sirtuin 5 (SIRT5) is crucial for melanoma cell survival and proliferation, regardless of genetic mutations. Targeting SIRT5 could offer a new treatment strategy for various melanoma types.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cutaneous melanoma is a lethal skin cancer with limited durable remission rates for advanced cases.
  • Current therapies like immune checkpoint inhibitors and targeted treatments benefit only about half of advanced melanoma patients.
  • Sirtuin 5 (SIRT5), a protein deacetylase, regulates cellular metabolism and biological functions.

Purpose of the Study:

  • To investigate the role of SIRT5 in the proliferation and survival of cutaneous and uveal melanoma cells.
  • To determine if SIRT5 is essential for melanoma tumor formation in preclinical models.
  • To elucidate the molecular mechanisms by which SIRT5 influences melanoma gene expression.

Main Methods:

  • Assessed SIRT5's requirement for melanoma cell proliferation and survival across various genotypes.
  • Utilized melanoma xenograft and autochthonous mouse models to evaluate tumor formation.
  • Performed metabolite and transcriptomic analyses to understand SIRT5's impact on histone modifications and gene expression.

Main Results:

  • SIRT5 is essential for the proliferation and survival of all tested cutaneous and uveal melanoma genotypes.
  • SIRT5 deficiency impaired melanoma xenograft tumor formation and development in a Braf Pten-driven mouse model.
  • SIRT5 maintains histone acetylation and methylation levels, crucial for regulating genes like MITF and c-MYC.

Conclusions:

  • SIRT5 is a critical factor for melanoma cell viability and tumorigenesis, independent of specific genetic mutations.
  • SIRT5 regulates key oncogenes, including MITF and c-MYC, through epigenetic modifications.
  • SIRT5 presents a potential druggable target for melanoma treatment across different subtypes.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Chromatin Modification in iPS Cells01:32

Chromatin Modification in iPS Cells

Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.0K
Spreading of Chromatin Modifications02:25

Spreading of Chromatin Modifications

The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
8.8K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.4K